Dr Roberto Alonzi

BSc, MB, BS, MRCP, FRCR, MD

Clinical oncologist

Special clinical interest in urological cancers, prostate cancer and bladder cancer.

Dr Alonzi is a Medical Research Council Clinician Scientist with a special interest in prostate cancer. He also has appointments as a Consultant Clinical Oncologist at Mount Vernon Cancer Centre and as a Senior Lecturer at University College London.

Dr Alonzi trained at Guy’s and St Thomas’ Hospitals in London. Following general training and membership of the Royal College of Physicians, he undertook specialist training at Hammersmith Hospital, Charing Cross Hospital, and Mount Vernon Cancer Centre, resulting in a Fellowship of the Royal College of Radiologists in 2004. He went on to complete his research degree at the Gray Cancer Institute and University College London and was awarded an MD in 2008.

Dr Alonzi currently sits on the National Cancer Research Institute, low-risk prostate cancer group and the bladder cancer chemo-radiotherapy group.

His research interests include the development of biologically targeted image-guided precision radiotherapy, tumour oxygenation, radiobiology and the use of radiation sensitisers in prostate cancer. He has also published work that characterises how the effects of hormone treatment can alter the biology of prostate tumours. This research is currently funded by the Medical Research Council, the Prostate Cancer Charity and the Royal College of Radiologists.

Treatments

  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Hormone therapy

Specialties

  • Urological cancer

NHS Hospital / current post(s)

  • Consultant Clinical Oncologist, East and North Herts NHS Mount Vernon Cancer Centre and Hemel Hempstead Hospital

Year qualified

1997

Research interests

  • Development of biologically targeted image-guided precision radiotherapy, tumour oxygenation, radiobiology and the use of radiation sensitisers in prostate cancer

Professional memberships

  • Fellow of the Royal College of Radiologists (FRCR)
  • Member of the Royal College of Physicians (MRCP)
  • Member of the European Society for Radiotherapy and Oncology (ESRO)
  • Member of the National Cancer Research Institute (NCRI)